Complex and Customized: Manufacturing New Molecular Formats

Increasingly complex monoclonal antibody molecules will require the right “tool box” for scaling up manufacturing.

Now that high yields have been achieved for the first generation of monoclonal antibodies, the next challenge will be developing ways to produce larger quantities of even more complex antibody formats. These increasingly complex molecules will require the right “tool box” for scaling up manufacturing.

Read this article in BioPharm International's Outsourcing Resources 2019 eBook.

Article Details

BioPharm International
eBook: Outsourcing Resources 2019
April 2019
Pages: 16–19

Citation

When referring to this article, please cite it as Andy Racher, "Complex and Customized: Manufacturing New Molecular Formats,"BioPharm International's Outsourcing Resources eBook (April 2019).

Articles in this issue

over 6 years ago

Article

Navigating the Biologics Wave

over 6 years ago

Article

CMC Due Diligence for Accelerated Biologic Drug Development and Manufacturing

over 6 years ago

Article

Emerging Therapies Test Existing Bioanalytical Methods

over 6 years ago

Article

Using the Multiple Attribute Method for Process Development and Quality Control

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!